Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis
Crossref DOI link: https://doi.org/10.1007/s13402-018-00420-0
Published Online: 2019-01-15
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Dingxie http://orcid.org/0000-0002-8061-5704
Text and Data Mining valid from 2019-01-15
Article History
Accepted: 26 December 2018
First Online: 15 January 2019
Compliance with ethical standards
:
: None declared.